UnitedHealth Group stock draws fresh analyst upgrades as earnings date nears

UnitedHealth Group heads toward its mid-July earnings release with multiple Wall Street firms lifting price targets and a steady position in the Dow Jones and S&P 500, underscoring how expectations are shifting for the largest U.S. health insurer.

By Anna Walker, Analysts & Consensus desk. Reviewed on June 30, 2026 at 2:57 p.m. ET.

UnitedHealth Group Incorporated (ISIN US91324P1021) approaches its next earnings release with a cluster of new analyst price target increases and a firmly established role in major U.S. equity benchmarks including the Dow Jones Industrial Average and the S&P 500. Recent data compiled by market portals shows the stock near $419 in late June trading on the New York Stock Exchange, after a prior close around $415 that outperformed the S&P 500 in a recent session.

Analysts lift UnitedHealth targets

Across several Wall Street desks, analysts have been revising their views on UnitedHealth Group with a series of upgrades and higher price objectives that underscore improving sentiment toward managed care. A detailed ratings dashboard from TrendSpider shows Bank of America Securities shifting its stance on UnitedHealth from Neutral to Buy and raising its price target from $420 to $450, alongside separate increases from Truist Securities, Bernstein and UBS that move their respective targets into the mid-$400s and above.

The clustered target moves come after UnitedHealth beaten first-quarter expectations earlier this year, with some analyst commentary highlighting improved medical cost ratios and confidence in the company’s medium-term earnings power. A synthesis of recent notes and commentary compiled by Intellectia.AI points to raised full-year 2026 adjusted earnings guidance to above $18.25 per share and operating cash flow of roughly $8.9 billion in the first quarter, supporting the more constructive analyst stance.

Earnings date and consensus expectations

With the next earnings release scheduled for July 16, 2026, expectations for UnitedHealth’s second quarter are increasingly central to the stock’s narrative. A market-data and analytics page on TrendSpider lists July 16, 2026 as the next earnings date and aggregates multiple Wall Street target changes, reinforcing the importance of that release for investors tracking managed care trends.

Consensus earnings and revenue expectations compiled by research outlet Zacks suggest UnitedHealth is forecast to report second-quarter earnings per share of $4.84, which would mark an 18.63 percent increase compared with the same quarter a year earlier, alongside revenue of about $110.05 billion, implying a modest 1.4 percent decline versus the prior-year quarter. Zacks also notes full-year 2026 consensus projections at roughly $18.32 per share of earnings and $443.7 billion of revenue, indicating expected double-digit profit growth even as top-line trends flatten.

Business mix between health benefits and services

UnitedHealth Group’s operating profile rests on two major platforms, UnitedHealthcare and Optum, which together span traditional health insurance, Medicare Advantage plans, Medicaid managed care, pharmacy benefits management, and data-driven healthcare services. As the largest U.S. health insurer by market capitalization, UnitedHealth has national reach across employer-sponsored plans, individual exchanges, and government programs, and it also offers integrated care models that connect insurance financing with clinical services and analytics.

Recent commentary compiled by Intellectia.AI highlights how management views technologies such as artificial intelligence as a potential lever across UnitedHealth’s revenue and cost base, from claims processing and fraud detection to clinical decision support. In analyst scenarios, efficiency gains from these tools could translate into meaningful upside in earnings per share over several years, provided implementation stays aligned with regulatory requirements and patient privacy standards.

UnitedHealth stock and recent price context

UnitedHealth shares currently trade on the New York Stock Exchange under the ticker UNH, with recent market-data pages such as MarketBeat and TradingKey showing prices around $419 to $419.44 in late June and a market capitalization near $380.85 billion. Zacks reports that in a recent trading session UnitedHealth closed at $415.53, representing a 2.4 percent gain versus the prior day, while the S&P 500 slipped 0.01 percent, the Dow gained 0.14 percent and the Nasdaq declined 0.46 percent, underscoring the stock’s relative strength against the broader U.S. market at that point.

For investors tracking near-term volatility, the combination of strong first-quarter results, raised full-year guidance, and multiple analyst target increases can set expectations for how the stock might react around the July 16, 2026 earnings release. At the same time, Intellectia.AI notes ongoing legal and regulatory risks linked to investigations into Medicare Advantage billing practices, reminding market participants that managed care remains exposed to policy shifts and oversight even when operating results look robust.

UnitedHealth Group key data

• Company: UnitedHealth Group Incorporated
• ISIN: US91324P1021
• Ticker: UNH
• Exchange: New York Stock Exchange (NYSE)
• Price (as of June 29, 2026, 4:00 p.m. ET): $419.44 USD
• Market cap: $380.85 billion (as of June 29, 2026)
• Sector / Industry: Health care - Managed care and health services
• Index membership: Dow Jones Industrial Average, S&P 500
• Next earnings date: July 16, 2026

This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.